Online Content
Keith Croes
Owner, Croes Copy
United States
| Writer | Editor | Consultant |
All types of media. All types of audiences. All types of experience.
United States
| Writer | Editor | Consultant |
All types of media. All types of audiences. All types of experience.
Online Content
Once again the eye proved to be the pioneer target in a new gene therapy approach, with the use in February of an agent utilizing in vivo CRISPR to treat an inherited retinal disease (IRD). Editas' EDIT-101 (also known as AGN-151587), began Phase I/II clinical trials for treating Leber's congenital amaurosis 10 (LCA10), the most...
Media coverage of AbbVie's (NYSE: ABBV) acquisition of Allergan (NYSE: AGN) in June was both bullish and bearish. In our initial coverage, we took a line from the joint press release-"...a transformative move for both companies"-which can't be wrong no matter what happens. Let's look a little at that initial coverage.
Globally, the myopia market may be worth upwards of $28 billion by 2026, with single prescription corrective lenses holding a significant market share, according to one report. CooperVision's first contact lens indicated to slow the progression of myopia in children was approved in mid-November and may garner an impressive part of that market share -...
Over the past 10 years, the Dow Jones Industrial Average has seen a 10-year climb with small calendar-year dips seen in 2015 (-2.23%) and 2018 (-5.63%), but topping out at around 28,000 toward the end of 2019. Investors can only wonder: How long can that bull market last?
Days after the U.S. Food and Drug Administration placed a partial hold on RGX-314, RegenxBio (NASDAQ: RGNX) lead gene therapy agent, the company initially outlined common responses (delaying an investigational new drug [IND], continued assessment and monitoring, etc.), but then did something completely unexpected - it sued the FDA, seeking to set the hold aside,...
It's been a good year for Opthea Ltd., a biotechnology company based in Melbourne, Australia. It's listed on the Australian Securities Exchange (ASX), trading as OPT. Opthea is a top performer in the OIS Index of ophthalmic biotech and biopharma companies. While the OIS Index was down 12.0% over the 3 months from July through...
CHICAGO-The first gene therapy approved in the United States happened to be for an inherited eye disease, with an agent that is administered subretinally. But investigators are actively examining therapies for other eye-related genetic diseases and other routes of delivery. Investors, of course, are closely following the progress.
CHICAGO - Optimal treatment of retinal diseases hinges on better understanding in three primary areas, said an expert panel at OIS@ASRS 2019: the disease mechanisms involved; individual patient differences; and the timing of injections. A fourth point involves treatment yet to be developed: A safe, effective, long-term delivery system for anti-VEGF agents.
Early market reaction to Glaukos Corp.'s all-stock acquisition of Avedro Inc. was mixed; a decrease in stock price for Glaukos and an increase for Avedro. Despite that lukewarm reaction, the acquisition has the potential to bring together companies with complementary platforms and improve Glaukos' scale for R&D.
CHICAGO - The extensive, intensive public and private investment in the retinal space will fill the day next Thursday, July 25, at the OIS@ASRS meeting, to be held at the Ritz-Carlton here. The 2019 program will cover late-breaking clinical data, corporate strategies, and financial insights from a dynamic mix of private and public companies and...
NEW YORK - In what's been called "a transformative move for both companies," AbbVie has agreed to buy Allergan in a deal valued at $63 billion. Reaction from the investor community was deeply mixed. The announcement on Tuesday set off the worst day for AbbVie's stock since it was spun off from its parent company, Abbot Laboratories, closing down 16% to $65.70 per share.
SAN DIEGO - Although the 10-year bull market is bound to end one of these days, the trend in ophthalmology and healthcare in general is a continued strong year, according to J.P. Peltier, managing director, global head, healthcare investment banking at Piper Jaffray.
Take this two-minute screening test to learn if you are a good candidate for LASIK surgery.
Technique for making LASIK flap with a laser vs a microkeratome
QualitySolutions360 is committed to providing healthcare stakeholders with resources to help navigate change while improving care and access to medications patients need.
Feature on optometric practice in Las Vegas
Online CME for urologists
Online CME for obstetricians/gynecologists
A CME course for urologists, primary care physicians, and obstetricians/gynecologists
Online CME for primary care physicians
Books
Chapters from the world's leading refractive surgeons. Keith Croes wrote and edited one of the chapters.
This is the story of one of the world s most successful medical prosthetic devices as told by those who lived it. Keith Croes captured ophthalmologist Herve Byron's vision, coordinating and editing submissions from the world's leading vision practitioners and researchers. Byron died in 2012 at the age of...
Dr. Noel Alpins developed the Alpins Method of astigmatism analysis to provide accurate planning and analysis of astigmatism procedures. His method focuses on analyzing refractive and corneal astigmatism parameters and using the results in future surgery to improve visual outcomes. Dr. Alpins pioneered small-incision cataract surgery in Victoria, Australia, in 1987 and then became a founder and current member of the Excimer Laser & Research Group. He has specialized in cataract and...
Fantasy Crow begins a trilogy of short-story collections with the mission of following imagination into whatever landscape attracts it. There are echoes of the masters here -- Asimov, Heinlein, Bradbury, and others. But the stories, with a modern edge, stand on their own.
Funny how fantasy and science fiction often can't be placed in any particular moment, past or future. Keith Croes finds the everyday magic in every now. Welcome to the present.
Humankind will someday go to the stars. And rock-and-roll will go along, as will parenthood, beagles, heroism, and scotch. A lot of books will be and have been written about what someone someday will do. But this is the last of the short-story collections Keith Croes will write at the particular point in his life when these were written. Peace out.
Social Media
The latest from ASSORT Pty Ltd (@ASSORTastig). ASSORT is a total ophthalmic surgical analysis system, which includes the Alpins Method of astigmatism analysis. Melbourne, Australia
Eve's Meditations. 128 likes · 12 talking about this. Eve's Meditations is a beautiful set of 45 cards containing creative meditations and images intended to enliven your spirit. The set is divided...
Healing Vocal Tones. 21 likes · 11 talking about this. Alternative & Holistic Health Service
Vocal toning training, healing, and meditations from Elizabeth Peters.
Monographs for Print or Digital
Refined in KOL meetings; used by speakers throughout country to describe the renal anemia management period (RAMP).
PowerPoint Presentations and iPad Assets
In-service presentation for OCHWW editors. Contact me for a copy of the original PowerPoint show.
Refined over the course of 8 advisory board meetings
Print Periodicals, Newsletters, and Articles
CME newsletter
Letter to the editor of Archives of Ophthalmology, written by Keith Croes in response to an editorial related to prior publication of peer-reviewed articles.
News article on potentially illegal modification of LASIK lasers
Primary Care Optometry News | --- Keith Croes. The public's perception of photorefractive keratectomy (PRK)--and the eye care professionals who provide it--will have a huge impact on the volume of surgery that is ultimately performed. Equally as important--and perhaps related to this--is the attitude of optometrists who provide primary eye care.
Involved in cover design and all content
For Barrie AM
Published by W.B. Saunders; Elander R, Rich L, Robin J, eds.
Article published online and in print
Report from stringer Keith Croes based on events at a municipal hearing.
Animations
Press Releases
Commissioned by the country of New Zealand.
Convention Panels, Brochures, Miscellaneous
Displayed at professional meeting
In 2014 seniors were affected by a coverage gap that was not widely understood. This is the final draft of a brochure sent to practitioners who in turn offered it to their patients.
Catalog of products from advertisers in the monthly magazine
Flyer created for J&J for handout to customers, describing their partnership with Walmart.
Nice Things People Say
October 15, 2019: Sheraz Daya posted images on LinkedIn